Tudor Investment Corp
ARIA

Tudor Investment Corp’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Tudor Investment Corp’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,400
Closed -$158K – 1884
2016
Q2 		$158K Sell
21,400
-5,669
-21% -$42.5K ﹤0.01% 1456
2016
Q1 		$173K Buy
27,069
+7,400
+38% +$41.5K ﹤0.01% 1536
2015
Q4 		$123K Buy
+19,669
New +$129K ﹤0.01% 1509
2015
Q3 		– Sell
-13,545
Closed -$112K – 1881
2015
Q2 		$112K Sell
13,545
-2,050
-13% -$18.1K ﹤0.01% 1408
2015
Q1 		$129K Sell
15,595
-11,632
-43% -$86K ﹤0.01% 1356
2014
Q4 		$187K Buy
+27,227
New +$170K 0.01% 1290
2014
Q1 		– Sell
-18,432
Closed -$126K – 1536
2013
Q4 		$126K Buy
+18,432
New +$99.5K 0.01% 1182

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Tudor Investment Corp's ARIA Position: Q3 2016 in Review

Tudor Investment Corp sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 21,400 shares — an estimated $158K sold.

Tudor Investment Corp first reported a position in ARIA in Q4 2013 and held it in 7 quarters. The position peaked at $187K in Q4 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Tudor Investment Corp reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 21,400 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $158K.
  • Tudor Investment Corp first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 7 quarters.
  • Tudor Investment Corp's Ariad Pharmaceuticals Inc position peaked at $187K in Q4 2014.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Tudor Investment Corp's 13F filing for Q3 2016, filed 14 Nov 2016.